1. Dohrmann, GJ, Farwell, JR, Flannery, JT. Glioblastoma multiforme in children. J Neurosurg 1976; 44: 442–448. DOI: 10.3171/jns.1976.44.4.0442.
Google Scholar | Crossref | Medline | ISI2. Ostrom, QT, Cioffi, G, Gittleman, H, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016. Neuro Oncol 2019; 21: v1–v100. DOI: 10.1093/neuonc/noz150.
Google Scholar | Crossref | Medline3. Ostrom, QT, Patil, N, Cioffi, G, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro Oncol 2020; 22: iv1–iv96. DOI: 10.1093/neuonc/noaa200.
Google Scholar | Crossref | Medline4. Sanchez-Herrera, F, Castro-Sierra, E, Gordillo-Dominguez, LF, et al. Glioblastoma multiforme in children: experience at Hospital Infantil de Mexico Federico Gomez. Childs Nerv Syst 2009; 25: 551–557. DOI: 10.1007/s00381-008-0780-8.
Google Scholar | Crossref | Medline | ISI5. Song, D, Xu, D, Gao, Q, et al. Intracranial metastases originating from pediatric primary spinal cord glioblastoma multiforme: a case report and literature review. Front Oncol 2020; 10: 99. DOI: 10.3389/fonc.2020.00099.
Google Scholar | Crossref | Medline6. Louis, DN, Perry, A, Wesseling, P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 2021; 23: 1231–1251. DOI: 10.1093/neuonc/noab106.
Google Scholar | Crossref | Medline7. Aboian, MS, Solomon, DA, Felton, E, et al. Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation. AJNR Am J Neuroradiol 2017; 38: 795–800. DOI: 10.3174/ajnr.A5076.
Google Scholar | Crossref | Medline8. Banan, R, Akbarian, A, Samii, M, et al. Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures. PLoS One 2021; 16: e0249647. DOI: 10.1371/journal.pone.0249647.
Google Scholar | Crossref | Medline9. Cheng, L, Wang, L, Yao, Q, et al. Clinicoradiological characteristics of primary spinal cord H3 K27M-mutant diffuse midline glioma. J Neurosurg Spine 2021; 1–12. DOI: 10.3171/2021.4.SPINE2140.
Google Scholar | Crossref10. Cheng, R, Li, DP, Zhang, N, et al. Spinal cord diffuse midline glioma with histone H3 K27M mutation in a pediatric patient. Front Surg 2021; 8: 616334. DOI: 10.3389/fsurg.2021.616334.
Google Scholar | Crossref | Medline11. Kraus, TFJ, Machegger, L, Poppe, J, et al. Diffuse midline glioma of the cervical spinal cord with H3 K27M genotype phenotypically mimicking anaplastic ganglioglioma: a case report and review of the literature. Brain Tumor Pathol 2020; 37: 89–94. DOI: 10.1007/s10014-020-00365-z.
Google Scholar | Crossref | Medline12. Kumar, A, Rashid, S, Singh, S, et al. Spinal cord diffuse midline glioma in a 4-Year-Old Boy. Child Neurol Open 2019; 6: 2329048X1984245. DOI: 10.1177/2329048X19842451.
Google Scholar | SAGE Journals13. Navarro, RE, Golub, D, Hill, T, et al. Pediatric midline H3K27M-mutant tumor with disseminated leptomeningeal disease and glioneuronal features: case report and literature review. Childs Nerv Syst 2021; 37: 2347–2356. DOI: 10.1007/s00381-020-04892-0.
Google Scholar | Crossref | Medline14. Uppar, A, Konar, SK, Nandeesh, BN, et al. H3K27M-positive primary spinal glioblastoma presenting with hemorrhage-a rare clinical entity. World Neurosurg 2019; 126: 223–227. DOI: 10.1016/j.wneu.2019.03.025.
Google Scholar | Crossref | Medline15. Wang, L, Li, Z, Zhang, M, et al. H3 K27M-mutant diffuse midline gliomas in different anatomical locations. Hum Pathol 2018; 78: 89–96. DOI: 10.1016/j.humpath.2018.04.015.
Google Scholar | Crossref | Medline16. Yao, J, Wang, L, Ge, H, et al. Diffuse midline glioma with H3 K27M mutation of the spinal cord: a series of 33 cases. Neuropathology 2021; 41: 183–190. DOI: 10.1111/neup.12714.
Google Scholar | Crossref | Medline17. Cohen, KJ, Pollack, IF, Zhou, T, et al. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children’s Oncology Group. Neuro Oncol 2011; 13: 317–323. DOI: 10.1093/neuonc/noq191.
Google Scholar | Crossref | Medline18. Louis, DN, Ohgaki, H, Wiestler, OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97–109. DOI: 10.1007/s00401-007-0243-4.
Google Scholar | Crossref | Medline | ISI19. Louis, DN, Perry, A, Reifenberger, G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016; 131: 803–820. DOI: 10.1007/s00401-016-1545-1.
Google Scholar | Crossref | Medline | ISI20. Louis, DN, Ohgaki, H, Wiestler, OD, et al. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon: IARC Press; International Agency for Research on Cancer, 2016.
Google Scholar21. Ferrante, P, Mora, JA, Salazar, L, et al. MR imaging findings in primary spinal cord glioblastoma. Radiol Case Rep 2021; 16: 72–77. DOI: 10.1016/j.radcr.2020.10.043.
Google Scholar | Crossref | Medline22. Koeller, KK, Rosenblum, RS, Morrison, AL. Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Radiographics 2000; 20: 1721–1749. DOI: 10.1148/radiographics.20.6.g00nv151721.
Google Scholar | Crossref | Medline | ISI23. Konar, SK, Bir, SC, Maiti, TK, et al. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord. J Neurosurg Pediatr 2017; 19: 239–248. DOI: 10.3171/2016.8.PEDS1631.
Google Scholar | Crossref | Medline24. Wolff, B, Ng, A, Roth, D, et al. Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database. J Neurooncol 2012; 107: 139–146. DOI: 10.1007/s11060-011-0718-y.
Google Scholar | Crossref | Medline25. Ononiwu, C, Mehta, V, Bettegowda, C, et al. Pediatric spinal glioblastoma multiforme: current treatment strategies and possible predictors of survival. Childs Nerv Syst 2012; 28: 715–720. DOI: 10.1007/s00381-012-1705-0.
Google Scholar | Crossref | Medline26. Birzu, C, Tran, S, Bielle, F, et al. Leptomeningeal spread in glioblastoma: diagnostic and therapeutic challenges. Oncologist 2020; 25: e1763–e1776. DOI: 10.1634/theoncologist.2020-0258.
Google Scholar | Crossref | Medline27. Sturm, D, Witt, H, Hovestadt, V, et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 2012; 22: 425–437. DOI: 10.1016/j.ccr.2012.08.024.
Google Scholar | Crossref | Medline | ISI28. Yan, H, Parsons, DW, Jin, G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009; 360: 765–773. DOI: 10.1056/NEJMoa0808710.
Google Scholar | Crossref | Medline | ISI29. Cohen, AR, Wisoff, JH, Allen, JC, et al. Malignant astrocytomas of the spinal cord. J Neurosurg 1989; 70: 50–54. DOI: 10.3171/jns.1989.70.1.0050.
Google Scholar | Crossref | Medline | ISI30. Kleinschmidt-DeMasters, BK, Mulcahy Levy, JM. H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis. Clin Neuropathol 2018; 37: 53–63. DOI: 10.5414/NP301085.
Google Scholar | Crossref | Medline31. Onda, K, Tanaka, R, Takahashi, H, et al. Cerebral glioblastoma with cerebrospinal fluid dissemination: a clinicopathological study of 14 cases examined by complete autopsy. Neurosurgery 1989; 25: 533–540.
Google Scholar | Crossref | Medline32. Mandel, JJ, Yust-Katz, S, Cachia, D, et al. Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution. J Neurooncol 2014; 120: 597–605. DOI: 10.1007/s11060-014-1592-1.
Google Scholar | Crossref | Medline33. Noh, JH, Lee, MH, Kim, WS, et al. Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome. Acta Neurochir 2015; 157: 569–576. DOI: 10.1007/s00701-015-2344-5.
Google Scholar | Crossref | Medline34. Andersen, BM, Miranda, C, Hatzoglou, V, et al. Leptomeningeal metastases in glioma: the memorial Sloan Kettering Cancer Center experience. Neurology 2019; 92: e2483–e2491. DOI: 10.1212/WNL.0000000000007529.
Google Scholar | Crossref | Medline35. Civitello, LA, Packer, RJ, Rorke, LB, et al. Leptomeningeal dissemination of low-grade gliomas in childhood. Neurology 1988; 38: 562–566. DOI: 10.1212/wnl.38.4.562.
Google Scholar | Crossref | Medline36. Hukin, J, Siffert, J, Cohen, H, et al. Leptomeningeal dissemination at diagnosis of pediatric low-grade neuroepithelial tumors. Neuro Oncol 2003; 5: 188–196. DOI: 10.1215/S1152851702000297.
Google Scholar | Crossref | Medline37. Donson, AM, Addo-Yobo, SO, Handler, MH, et al. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Pediatr Blood Cancer 2007; 48: 403–407. DOI: 10.1002/pbc.20803.
Google Scholar | Crossref | Medline | ISI